Breakthrough research identifies TIM3 as a key target in MAPK-activated pediatric gliomas, offering new hope for more effective immunotherapy treatments. Despite being a leading cause of childhood ...
Originally hailing from Troy, Ohio, Ry Crist is a writer, a text-based adventure connoisseur, a lover of terrible movies and an enthusiastic yet mediocre cook. A CNET editor from 2013 to 2024, Ry's ...
Originally hailing from Troy, Ohio, Ry Crist is a writer, a text-based adventure connoisseur, a lover of terrible movies and an enthusiastic yet mediocre cook. A CNET editor from 2013 to 2024, Ry's ...
T cell membrane protein 3 (TIM3) is an immune checkpoint receptor that suppresses the activation of T helper 1 (T H 1) cells on engagement with ligand. It is also expressed by dendritic cells (DCs), ...
Priming immunotherapy with radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC) and head and neck squamous cell cancer (HNSCC): Interim analysis of phase II clinical trial. Safety of AK117 ...
Effect of ONC201 and bortezomib on apoptosis in non-Hodgkin' s lymphoma (NHL) xenografts. A cost-effectiveness analysis of DA-EPOCH-R versus R-CHOP for the treatment of diffuse large B-cell lymphoma.
Radiation treatment can boost the effectiveness of anti-cancer immunotherapy. Still, some patients fail to respond to this combination, and while the combination of radiotherapy and immunotherapy is ...
In the current landscape of cancer research, much attention is focused on the tumor microenvironment (TME) at both the primary site and established metastases. However, the early micrometastatic niche ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Sherwood Marketing is holding a voluntary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results